If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Regulatory News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

Share Price is delayed by 15 minutes
Get Live Data
1,554.00    30.00 (1.97%)
Bid:
1,561.00
Ask:
1,564.00
Spread: 3.00 (0.192%)
Market Cap: £3.27b
HIK Live PriceLast checked at - London Stock Exchange

Intraday Hikma Pharmaceuticals Share Chart

LTIP Awards

30 Apr 2008 15:22

Hikma Pharmaceuticals Plc30 April 2008 Hikma Pharmaceuticals PLC - LTIP Awards LONDON, 30 April 2008: Hikma Pharmaceuticals PLC (LSE: HIK) (DIFX: HIK)announces that the Remuneration Committee has made the following nil-cost awardsunder the Hikma Pharmaceuticals PLC 2005 Long-Term Incentive Plan (the "LTIP")to Directors and Persons Discharging Managerial Responsibility ("PDMRs") of theCompany. Awards under the LTIP were made on 29 April 2008 at a price of £4.64 perordinary share as follows:- Name of Director/PDMR Number of LTIP SharesSaid Darwazah 90,000Mazen Darwazah 54,000Bassam Kanaan 54,000Taghreed Al-Shunnar 54,000Majda Labadi 54,000Nabil Rizk 54,000 The shares subject to the LTIP awards will only be released to the participantsin three years time, subject to their continued employment and the satisfactionof the comparative Total Shareholder Return ("TSR") performance target.Participants will only receive the full benefit of their share incentives if TSRperformance against the Comparator Group is at least at the upper quartile. - ENDS -Enquiries: Hikma Pharmaceuticals PLCHenry Knowles +44 20 7399 2760Company Secretary Susan Ringdal +44 20 7399 2760Investor Relations Director About Hikma Hikma Pharmaceuticals PLC is a fast growing multinational group focused ondeveloping, manufacturing and marketing a broad range of both branded andnon-branded generic and in-licensed pharmaceutical products. Hikma's operationsare conducted through three businesses: "Branded", "Injectables" and"Generics". Hikma's operations are based principally in the Middle East andNorth Africa ("MENA") region, where it is a market leader and sells across 17countries, the United States and Europe. In 2007, the Group achieved revenuesof $449 million (2006 $317 million) and profit attributable to shareholders was$63 million (2006 $55 million). For news and other information, please visitwww.hikma.com. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
19th Nov 20093:07 pmRNSDirector/PDMR Shareholding
18th Nov 20094:37 pmRNSDirector/PDMR Shareholding
18th Nov 20094:29 pmRNSDirector/PDMR Shareholding
12th Nov 20097:00 amRNSInterim Management Statement
2nd Nov 200912:35 pmRNSTotal Voting Rights
20th Oct 200912:21 pmRNSBlocklisting Interim Review
16th Oct 200912:30 pmRNSDirector/PDMR Shareholding
1st Oct 200910:10 amRNSAdditional Listing
1st Oct 200910:04 amRNSTotal Voting Rights
27th Aug 20097:00 amRNSHalf Yearly Report
5th Aug 200911:51 amRNSTotal Voting Rights
17th Jul 20097:00 amRNSHikma signs licensing agreement
29th Jun 200911:58 amRNSDirector/PDMR Shareholding
19th May 200910:42 amRNSDirector/PDMR Shareholding
14th May 20096:12 pmRNSResult of AGM
14th May 20097:00 amRNSInterim Management Statement
12th May 20095:37 pmRNSAnnual Information Update
11th May 20092:08 pmRNSTotal Voting Rights
11th May 20091:57 pmRNSDirector/PDMR Shareholding
16th Apr 20094:00 pmRNSDirector/PDMR Shareholding
9th Apr 20093:59 pmRNSAnnual Financial Report
19th Mar 20095:02 pmRNSDirector/PDMR Shareholding
18th Mar 20094:39 pmRNSDirector/PDMR Shareholding
17th Mar 20097:00 amRNSFinal Results
26th Jan 200911:14 amRNSHolding(s) in Company
15th Jan 20093:58 pmRNSDirector/PDMR Shareholding
14th Jan 20097:00 amRNSTrading Statement
2nd Jan 200910:07 amRNSTotal Voting Rights
3rd Dec 20083:10 pmRNSTotal Voting Rights
25th Nov 20087:00 amRNSStatement re Injectables Presentation
5th Nov 20087:00 amRNSInterim Management Statement
3rd Nov 200810:40 amRNSTotal Voting Rights
22nd Oct 20089:42 amRNSBlocklisting Interim Review
17th Oct 20085:26 pmRNSDirector/PDMR Shareholding
13th Oct 20082:26 pmRNSDirector/PDMR Shareholding
3rd Oct 20084:51 pmRNSTotal Voting Rights
15th Sep 20085:21 pmRNSDirector/PDMR Shareholding
2nd Sep 20085:30 pmRNSTotal Voting Rights
28th Aug 20087:00 amRNSInterim Results
6th Aug 20089:25 amRNSTotal Voting Rights
21st Jul 20087:00 amRNSTrading Statement
2nd Jul 200811:53 amRNSTotal Voting Rights
25th Jun 20084:31 pmRNSDirector/PDMR Shareholding
25th Jun 200811:43 amRNSHolding(s) in Company
15th May 20085:18 pmRNSResults of Annual General Mee
15th May 200811:00 amRNSAGM and IMS
15th May 20089:07 amRNSTR-1: Notifications of Major
12th May 20082:37 pmRNSAnnual Information Update
30th Apr 20083:22 pmRNSLTIP Awards
15th Apr 20082:40 pmRNSNotice of Annual Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.